Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 149

1.

Hypertriglyceridemia: the importance of identifying patients at risk.

Kushner PA, Cobble ME.

Postgrad Med. 2016 Nov;128(8):848-858. Review.

PMID:
27710158
2.

Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.

Lotta LA, Sharp SJ, Burgess S, Perry JR, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, Boeing H, Deloukas P, Forouhi NG, Franks PW, Grioni S, Kaaks R, Key TJ, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Riboli E, Rolandsson O, Sacerdote C, Salamanca-Fernandez E, Slimani N, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, McCarthy MI, Barroso I, O'Rahilly S, Savage DB, Sattar N, Langenberg C, Scott RA, Wareham NJ.

JAMA. 2016 Oct 4;316(13):1383-1391. doi: 10.1001/jama.2016.14568.

PMID:
27701660
3.
4.

EFFICACY OF 5 MG AND 10 MG ROSUVASTATIN IN TYPE-2 DIABETES MELLITUS WITH HYPERCHOLESTEROALEMIA.

Ullah F, Afridi AK, Rahim F, ur Rahman S, Ashfaq M.

J Ayub Med Coll Abbottabad. 2015 Jul-Sep;27(3):564-8.

PMID:
26721008
5.

The SNP rs9677 of VPAC1 gene is associated with glycolipid control and heart function in female patients with type 2 diabetes: A follow-up study.

Tavaglione F, Filardi T, Fallarino M, Mandosi E, Turinese I, Rossetti M, Lenzi A, Morano S.

Nutr Metab Cardiovasc Dis. 2016 Feb;26(2):109-13. doi: 10.1016/j.numecd.2015.10.009.

PMID:
26712708
6.

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology.

Gyberg V, De Bacquer D, De Backer G, Jennings C, Kotseva K, Mellbin L, Schnell O, Tuomilehto J, Wood D, Rydén L, Amouyel P, Bruthans J, Conde AC, Cifkova R, Deckers JW, De Sutter J, Dilic M, Dolzhenko M, Erglis A, Fras Z, Gaita D, Gotcheva N, Goudevenos J, Heuschmann P, Laucevicius A, Lehto S, Lovic D, Miličić D, Moore D, Nicolaides E, Oganov R, Pająk A, Pogosova N, Reiner Z, Stagmo M, Störk S, Tokgözoğlu L, Vulic D; EUROASPIRE Investigators..

Cardiovasc Diabetol. 2015 Oct 1;14:133. doi: 10.1186/s12933-015-0296-y.

8.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators..

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107.

PMID:
26296047
9.

Lipid parameters in patients with acute coronary syndromes versus stable coronary artery disease.

Vonbank A, Saely CH, Rein P, Drexel H.

Eur J Clin Invest. 2015 Oct;45(10):1092-7. doi: 10.1111/eci.12513.

PMID:
26255620
10.

Liver fat, statin use, and incident diabetes: The Multi-Ethnic Study of Atherosclerosis.

Shah RV, Allison MA, Lima JA, Bluemke DA, Abbasi SA, Ouyang P, Jerosch-Herold M, Ding J, Budoff MJ, Murthy VL.

Atherosclerosis. 2015 Sep;242(1):211-7. doi: 10.1016/j.atherosclerosis.2015.07.018.

11.

Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).

Yeboah J, Sillau S, Delaney JC, Blaha MJ, Michos ED, Young R, Qureshi WT, McClelland R, Burke GL, Psaty BM, Herrington DM.

Am Heart J. 2015 Mar;169(3):387-395.e3. doi: 10.1016/j.ahj.2014.12.018.

12.

Alterations of plant sterols, lathosterol, oxidative stress and inflammatory markers after the combination therapy of ezetimibe and statin drugs in type 2 diabetic patients.

Naruse R, Hori K, Terasawa T, Hara K, Suetsugu M, Takebayashi K, Morita K, Aso Y, Inukai T.

Obes Res Clin Pract. 2015 Jan-Feb;9(1):67-74. doi: 10.1016/j.orcp.2014.02.001.

PMID:
25660177
13.

Impact of female sex on lipid lowering, clinical outcomes, and adverse effects in atorvastatin trials.

Hsue PY, Bittner VA, Betteridge J, Fayyad R, Laskey R, Wenger NK, Waters DD.

Am J Cardiol. 2015 Feb 15;115(4):447-53. doi: 10.1016/j.amjcard.2014.11.026.

PMID:
25637322
14.

Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.

Leśniak W, Bała MM, Płaczkiewicz-Jankowska E, Topór-Mądry R, Jankowski M, Sieradzki J, Banasiak W; ARETAEUS2 Study Group..

Cardiol J. 2015;22(2):150-9. doi: 10.5603/CJ.a2014.0067.

PMID:
25299503
15.

[Familial combined hyperlipidemia: consensus document].

Mata P, Alonso R, Ruíz-Garcia A, Díaz-Díaz JL, González N, Gijón-Conde T, Martínez-Faedo C, Morón I, Arranz E, Aguado R, Argueso R, Perez de Isla L.

Semergen. 2014 Oct;40(7):374-80. doi: 10.1016/j.semerg.2014.07.007. Spanish.

PMID:
25131181
16.

Very low density lipoprotein cholesterol associates with coronary artery calcification in type 2 diabetes beyond circulating levels of triglycerides.

Prenner SB, Mulvey CK, Ferguson JF, Rickels MR, Bhatt AB, Reilly MP.

Atherosclerosis. 2014 Oct;236(2):244-50. doi: 10.1016/j.atherosclerosis.2014.07.008.

17.

Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.

Edsfeldt A, Gonçalves I, Grufman H, Nitulescu M, Dunér P, Bengtsson E, Mollet IG, Persson A, Nilsson M, Orho-Melander M, Melander O, Björkbacka H, Nilsson J.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2143-50. doi: 10.1161/ATVBAHA.114.303414.

19.

Ectopic calcification in diabetic vascular disease.

Avogaro A, Rattazzi M, Fadini GP.

Expert Opin Ther Targets. 2014 May;18(5):595-609. doi: 10.1517/14728222.2014.894021. Review.

PMID:
24593833
20.

Diabetic dyslipidemia: from evolving pathophysiological insight to emerging therapeutic targets.

Ng DS.

Can J Diabetes. 2013 Oct;37(5):319-26. doi: 10.1016/j.jcjd.2013.07.062. Review.

PMID:
24500559

Supplemental Content

Loading ...
Support Center